npj Breast Cancer
Издатель: Springer Nature · ISSN 2374-4677 · 9 статей
-
Real-world rates and sites of recurrence after neoadjuvant chemoimmunotherapy in early-stage triple-negative breast cancer
npj Breast Cancer, Published online: 18 November 2026; doi:10.1038/s41523-026-01070-4 Real-world rates and sites of recurrence after neoadjuvant chemoimmunotherapy in early-stage triple-negative breast cancer
-
Directional mitochondrial transfer and microenvironmental adaptation in breast cancer
npj Breast Cancer, Published online: 16 November 2026; doi:10.1038/s41523-026-01079-9 Directional mitochondrial transfer and microenvironmental adaptation in breast cancer
-
Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics
npj Breast Cancer, Published online: 13 November 2026; doi:10.1038/s41523-026-01078-w Coordinated patterns of genomic instability and immunogenicity predict 10-year breast cancer progression across subtypes and patient characteristics
-
Nucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
npj Breast Cancer, Published online: 12 November 2026; doi:10.1038/s41523-026-01080-2 Nucleotide excision repair deficiency identified by mutational signatures is associated with cisplatin response in triple-negative breast cancer
-
Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1- and BRCA2-associated breast and ovarian cancer
npj Breast Cancer, Published online: 11 November 2026; doi:10.1038/s41523-026-01076-y Hypermethylation in CpG-rich cfDNA fragments enables accurate detection of circulating tumor DNA in BRCA1 - and BRCA2 -associated breast and ovarian cancer
-
First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation
npj Breast Cancer, Published online: 07 November 2026; doi:10.1038/s41523-026-01075-z First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation
-
BREST-AI: Three-year breast cancer risk prediction from screening mammograms
npj Breast Cancer, Published online: 27 October 2026; doi:10.1038/s41523-026-01069-x BREST-AI: Three-year breast cancer risk prediction from screening mammograms
-
Matched ER+/ER− breast cancer models reveal disparate estrogen effects in mammary and pulmonary premetastatic environments
npj Breast Cancer, Published online: 27 October 2026; doi:10.1038/s41523-026-01073-1 Matched ER+/ER − breast cancer models reveal disparate estrogen effects in mammary and pulmonary premetastatic environments
-
Interpretable machine learning models for oncotypedDX® prediction using clinicopathologic data: a brazilian cohort study
npj Breast Cancer, Published online: 26 October 2026; doi:10.1038/s41523-026-01065-1 Interpretable machine learning models for oncotypedDX ® prediction using clinicopathologic data: a brazilian cohort study